PureTech Health (PRTC) announced that the U.S. Food and Drug Administration has granted Fast Track designation to LYT-200, a first-in-class anti-galectin-9 monoclonal antibody, for the treatment ...
At close: 23 January at 16:35:01 GMT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback